Conversely, increased FBN1 signaling has been associated with pro-inflammatory microenvironments in metabolic disease [34], suggesting that elevated FBN1 may exacerbate TNF-α-mediated neuroinflammation. This evidence concerns the gene TNF and Other metabolic disease.